Cargando…
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905700/ https://www.ncbi.nlm.nih.gov/pubmed/34607349 http://dx.doi.org/10.1182/bloodadvances.2021004829 |
| _version_ | 1784665247441747968 |
|---|---|
| author | Tey, Siok-Keen Lane, Steven W. |
| author_facet | Tey, Siok-Keen Lane, Steven W. |
| author_sort | Tey, Siok-Keen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8905700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89057002022-03-09 Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation Tey, Siok-Keen Lane, Steven W. Blood Adv Point American Society of Hematology 2022-03-08 /pmc/articles/PMC8905700/ /pubmed/34607349 http://dx.doi.org/10.1182/bloodadvances.2021004829 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Point Tey, Siok-Keen Lane, Steven W. Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title | Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title_full | Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title_fullStr | Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title_full_unstemmed | Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title_short | Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation |
| title_sort | better the cure you know: why patients with aml ≥60 years of age should be offered early allogeneic stem cell transplantation |
| topic | Point |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905700/ https://www.ncbi.nlm.nih.gov/pubmed/34607349 http://dx.doi.org/10.1182/bloodadvances.2021004829 |
| work_keys_str_mv | AT teysiokkeen betterthecureyouknowwhypatientswithaml60yearsofageshouldbeofferedearlyallogeneicstemcelltransplantation AT lanestevenw betterthecureyouknowwhypatientswithaml60yearsofageshouldbeofferedearlyallogeneicstemcelltransplantation |